Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1103 | 979 | 1150 | 1311 | 1302 | 1728 |
Fund Return | 10.32% | -2.14% | 15.04% | 9.44% | 5.42% | 5.62% |
Place in category | 183 | 299 | 228 | 80 | 131 | 95 |
% in Category | 41 | 63 | 51 | 18 | 35 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CF Canlife Global Equity Fund C Acc | 14.23M | 19.51 | 9.50 | 11.69 | ||
CF Canlife Portfolio V Fund C Acc | 154.88M | 8.85 | 3.79 | 5.75 | ||
CF Canlife North American Fund C Ac | 21.02M | 23.25 | 10.82 | 14.08 | ||
CF Canlife Portfolio III Fund C Acc | 39.29M | 4.66 | -0.08 | 3.02 | ||
CF Canlife Portfolio III Fund C Inc | 1.38M | 4.66 | -0.08 | 3.02 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.03B | 15.57 | 10.25 | 7.09 | ||
TB Evenlode Income B Income | 3.02B | 5.05 | 5.00 | 8.26 | ||
UK Equity Income Fund Institutional | 89.69M | 12.34 | 7.85 | 6.66 | ||
UK Equity Income Fund Retail Accumu | 116.37M | 11.76 | 7.26 | 6.05 | ||
UK Equity Income Fund Retail Income | 136.11M | 11.77 | 7.27 | 6.06 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 8.31 | 10,988.0 | +2.18% | |
Shell | GB00BP6MXD84 | 8.06 | 31.55 | +0.99% | |
Unilever | GB00B10RZP78 | 6.75 | 54.74 | +0.92% | |
HSBC | GB0005405286 | 3.85 | 802.50 | +1.43% | |
National Grid | GB00BDR05C01 | 3.75 | 934.80 | +0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Neutral | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review